SELL and cancer: It has been reported that the latter leads to the downregulation of the homing receptor CD62L (L-selectin) on T cells (24).When it comes to effective anti-cancer immunity, and for purposes of action, it requires the transportation to the tumour of activated T cells and the activation of tumour-reactive T cells.